A Prospective Cohort Study on Primary Cutaneous Amyloidosis

NCT06998875 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Primary Cutaneous Amyloidosis

Interventions

DRUG: Tofacitinib and Acitretin Capsules.
DRUG: Acitretin Capsules.

Sponsor

Army Medical University, China